Tags

Type your tag names separated by a space and hit enter

The effects of implementation of the Surviving Sepsis Campaign in the Netherlands.
Neth J Med. 2011 Jun; 69(6):292-8.NJ

Abstract

To reduce unintentional and avoidable adverse events in patients in hospitals in the Netherlands, a patient safety agency (VMS) programme was launched in 2008. Among the VMS topics, the programme 'optimal therapy in severe sepsis', according to the international Surviving Sepsis Campaign (SSC), aims to improve early diagnosis and treatment of sepsis to reduce sepsis mortality by 15% before the end of 2012. We analysed compliance data submitted to the international SSC database from the Netherlands and compared these data with published international SS C results. Data of 863 patients, representing 6% of the international data (n=14,209), were used for analysis. In the Netherlands, the resuscitation bundle compliance improved significantly from 7% at baseline to 27% after two years (p=0.002). Internationally, the resuscitation bundle compliance increased significantly from 11 to 31% (p.

Links

FREE Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Tromp M
Nijmegen Institute for Infection, Inflammation, and Immunity (N4i), Radboud University Nijmegen Medical Centre, the Netherlands. m.tromp@aig.umcn.nl
Tjan DH
No affiliation info available
van Zanten AR
No affiliation info available
Gielen-Wijffels SE
No affiliation info available
Goekoop GJ
No affiliation info available
van den Boogaard M
No affiliation info available
Wallenborg CM
No affiliation info available
Biemond-Moeniralam HS
No affiliation info available
Pickkers P
No affiliation info available

MeSH

AdultEarly DiagnosisGuideline AdherenceHealth Plan ImplementationHospital MortalityHumansNetherlandsPatient SafetySepsisSurvival Analysis

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21868818

Citation

Tromp, M, et al. "The Effects of Implementation of the Surviving Sepsis Campaign in the Netherlands." The Netherlands Journal of Medicine, vol. 69, no. 6, 2011, pp. 292-8.
Tromp M, Tjan DH, van Zanten AR, et al. The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. Neth J Med. 2011;69(6):292-8.
Tromp, M., Tjan, D. H., van Zanten, A. R., Gielen-Wijffels, S. E., Goekoop, G. J., van den Boogaard, M., Wallenborg, C. M., Biemond-Moeniralam, H. S., & Pickkers, P. (2011). The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. The Netherlands Journal of Medicine, 69(6), 292-8.
Tromp M, et al. The Effects of Implementation of the Surviving Sepsis Campaign in the Netherlands. Neth J Med. 2011;69(6):292-8. PubMed PMID: 21868818.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. AU - Tromp,M, AU - Tjan,D H T, AU - van Zanten,A R H, AU - Gielen-Wijffels,S E M, AU - Goekoop,G J D, AU - van den Boogaard,M, AU - Wallenborg,C M, AU - Biemond-Moeniralam,H S, AU - Pickkers,P, PY - 2011/8/27/entrez PY - 2011/8/27/pubmed PY - 2012/1/5/medline SP - 292 EP - 8 JF - The Netherlands journal of medicine JO - Neth J Med VL - 69 IS - 6 N2 - To reduce unintentional and avoidable adverse events in patients in hospitals in the Netherlands, a patient safety agency (VMS) programme was launched in 2008. Among the VMS topics, the programme 'optimal therapy in severe sepsis', according to the international Surviving Sepsis Campaign (SSC), aims to improve early diagnosis and treatment of sepsis to reduce sepsis mortality by 15% before the end of 2012. We analysed compliance data submitted to the international SSC database from the Netherlands and compared these data with published international SS C results. Data of 863 patients, representing 6% of the international data (n=14,209), were used for analysis. In the Netherlands, the resuscitation bundle compliance improved significantly from 7% at baseline to 27% after two years (p=0.002). Internationally, the resuscitation bundle compliance increased significantly from 11 to 31% (p. SN - 1872-9061 UR - https://www.unboundmedicine.com/medline/citation/21868818/The_effects_of_implementation_of_the_Surviving_Sepsis_Campaign_in_the_Netherlands_ L2 - http://www.njmonline.nl/njm/getarticle.php?v=69&i=6&p=292 DB - PRIME DP - Unbound Medicine ER -